Cite
Prevention of immunotoxin-induced immunogenicity by coadministration with CTLA4Ig enhances antitumor efficacy
MLA
C B Siegall, et al. “Prevention of Immunotoxin-Induced Immunogenicity by Coadministration with CTLA4Ig Enhances Antitumor Efficacy.” The Journal of Immunology, vol. 159, Nov. 1997, pp. 5168–73. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9a1e389a1f743d49e3c0000cbf17fe61&authtype=sso&custid=ns315887.
APA
C B Siegall, H G Haggerty, G L Warner, D Chace, B Mixan, P S Linsley, & T Davidson. (1997). Prevention of immunotoxin-induced immunogenicity by coadministration with CTLA4Ig enhances antitumor efficacy. The Journal of Immunology, 159, 5168–5173.
Chicago
C B Siegall, H G Haggerty, G L Warner, D Chace, B Mixan, P S Linsley, and T Davidson. 1997. “Prevention of Immunotoxin-Induced Immunogenicity by Coadministration with CTLA4Ig Enhances Antitumor Efficacy.” The Journal of Immunology 159 (November): 5168–73. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9a1e389a1f743d49e3c0000cbf17fe61&authtype=sso&custid=ns315887.